Anthropic’s 2026 strategy is to convert frontier AI research into a widely used enterprise and developer platform while financing extraordinary computing needs. Its October 2026 IPO filing reveals rapid growth and improving operating economics, but also capital intensity, cloud dependence and an unusual governance structure. Strategy must be evaluated through revenue quality, model capability, infrastructure economics and execution risks.
BAT’s 2026 strategy combines cash generation from established cigarette brands with investment in newer nicotine categories, while managing regulatory exposure, debt and shareholder distributions. This article examines the strategy’s economic trade-offs rather than endorsing tobacco or nicotine consumption.
BP’s 2026 strategy centres on upstream returns, downstream competitiveness and a stronger balance sheet. After the 2025 strategic reset, chief…
Unilever’s business strategy in 2026: Power Brands, portfolio transformation, innovation, emerging markets, margins and the proposed Foods combination with McCormick.
A detailed 2026 analysis of AstraZeneca business strategy using 2025 annual disclosures and 2026 interim results.
Detailed, evidence-based analysis of AstraZeneca business strategy in 2026 using annual and interim results.
A detailed examination of HSBC business strategy in 2026 using the bank’s 2025 annual report and 2026 interim results.
Mapletree Industrial Trust Business Strategy in 2026: financial performance, revenue drivers, competitive position, risks and 2026 outlook.